Penwest Pharmaceuticals Company Profile
Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting ingredients for the pharmaceuticalindustry, the Company has developed its proprietary TIMERx(R) controlled release drug delivery technology, which is applicable to a broad range of orally administered drugs, and Prosolv SMCC(TM), another drug delivery technology.
39 Old Ridgebury Road
United States of America
Return to top 50 pharma list Summary Website: Endo Pharmaceuticals Headquarters: Chadds Ford, Pennsylvania Ticker Symbol: ENDP : NASDAQ SEC Link: Endo Pharmaceuticals SEC filings Subsidiaries: Am...
Dermatology-focused [Trevi Therapeutics Inc.] has raised $10mm through its Series A venture round. TPG Biotech, Trevi’s seed backer, was the sole investor. Formed in 2011 by Jennifer Good and Dr....
Drugs and Medications
Penwest develops pharmaceutical products based on innovative proprietary drug delivery technologies. We are focusing our development efforts principally on products that address disorders of the nervo...
Penwest Pharmaceuticals is engaged in the research, development and commercialization of novel drug delivery technologies. Based on its extensive expertise in developing and manufacturing tabletting i...
More Information about "Penwest Pharmaceuticals" on BioPortfolio
We have published hundreds of Penwest Pharmaceuticals news stories on BioPortfolio along with dozens of Penwest Pharmaceuticals Clinical Trials and PubMed Articles about Penwest Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Penwest Pharmaceuticals Companies in our database. You can also find out about relevant Penwest Pharmaceuticals Drugs and Medications on this site too.